GEODE CAPITAL MANAGEMENT, LLC - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 26 filers reported holding TSCAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$788,582
+169.9%
307,938
+163.4%
0.00%
Q2 2023$292,227
+38.5%
116,891
+16.4%
0.00%
Q1 2023$210,928
+129303.7%
100,4420.0%0.00%
Q4 2022$163
-99.9%
100,442
-0.2%
0.00%
Q3 2022$307,000
+186.9%
100,669
+195.2%
0.00%
Q2 2022$107,000
+16.3%
34,101
+2.8%
0.00%
Q1 2022$92,000
-19.3%
33,159
+30.4%
0.00%
Q4 2021$114,000
+7.5%
25,421
+98.8%
0.00%
Q3 2021$106,00012,7860.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,612,80033.20%
Lynx1 Capital Management LP 5,224,600$13,374,9768.85%
EcoR1 Capital, LLC 5,000,000$12,800,0000.43%
Deer Management Co. LLC 1,245,505$3,188,4930.39%
Simplify Asset Management Inc. 1,046,916$2,680,1050.31%
BVF INC/IL 2,989,474$7,653,0530.21%
Alphabet Inc. 1,077,080$2,757,3240.18%
DC Investments Management, LLC 35,563$91,0410.11%
Baker Brothers Advisors 2,784,792$7,129,0680.04%
Privium Fund Management (UK) Ltd 15,825$41,4620.03%
View complete list of TSCAN THERAPEUTICS INC shareholders